Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP).
Carlos CampsJ J Reina ZoiloD Monge MartínF Caballero MartínezV Guillem PortaE Aranda AguilarA Carrato MenaE Díaz-Rubio GarcíaJ García-Foncillas LópezM Feijóo SausR López LópezPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2018)
Clinical inertia is a serious problem in the handling of BTcP in medical oncology services, where it is the subject of a significantly low level of detection and treatment, despite the contrasting perception of specialists.